Acute Porphyria Drug Database

V08CA09 - Gadobutrol
Not porphyrinogenic
NP

Rationale
Gadobutrol is not metabolised. It is excreted unchanged through the kidneys.
Chemical description
Gadobutrol is a nonionic gadolinium chelate.
Therapeutic characteristics
Gadobutrol is used as a magnetic resonance contrast medium. It is administered intravenously.
Hepatic exposure
Not significant.
Metabolism and pharmakokinetics
Gadobutrol is not metabolised and more than 90% of a dose is excreted in the urine within 12 hours.

References

  1. Drug reference publications
  2. Sweetman SC, editor. Martindale: The complete drug reference. Gadobutrol. Pharmaceutical Press 2009. #2970
  3. Summary of Product Characteristics
  4. Norwegian medicines agency. Summary of Product Characteristics (SPC). Gadovist. #2969

Similar drugs
Explore alternative drugs in similar therapeutic classes V08C / V08CA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙